DE60303872D1 - Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin - Google Patents

Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin

Info

Publication number
DE60303872D1
DE60303872D1 DE60303872T DE60303872T DE60303872D1 DE 60303872 D1 DE60303872 D1 DE 60303872D1 DE 60303872 T DE60303872 T DE 60303872T DE 60303872 T DE60303872 T DE 60303872T DE 60303872 D1 DE60303872 D1 DE 60303872D1
Authority
DE
Germany
Prior art keywords
desmopressin
preparation
dosage form
oral dosage
solid oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60303872T
Other languages
English (en)
Other versions
DE60303872T2 (de
Inventor
Kristin Wannerberger
Hans Dr Lindner
Lars-Erik Olsson
Ann Elisabeth Svensson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34560171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60303872(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring BV filed Critical Ferring BV
Publication of DE60303872D1 publication Critical patent/DE60303872D1/de
Application granted granted Critical
Publication of DE60303872T2 publication Critical patent/DE60303872T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60303872T 2003-12-29 2003-12-29 Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin Expired - Lifetime DE60303872T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (de) 2003-12-29 2003-12-29 Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin

Publications (2)

Publication Number Publication Date
DE60303872D1 true DE60303872D1 (de) 2006-05-04
DE60303872T2 DE60303872T2 (de) 2006-10-19

Family

ID=34560171

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60303872T Expired - Lifetime DE60303872T2 (de) 2003-12-29 2003-12-29 Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin

Country Status (12)

Country Link
EP (1) EP1550439B1 (de)
AR (1) AR047155A1 (de)
AT (1) ATE319430T1 (de)
DE (1) DE60303872T2 (de)
DK (1) DK1550439T3 (de)
ES (1) ES2254858T3 (de)
HK (1) HK1079696A1 (de)
IL (3) IL189107A0 (de)
NO (1) NO20045657L (de)
PT (1) PT1550439E (de)
SI (1) SI1550439T1 (de)
TW (1) TWI282284B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2584456C (en) * 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
LT3225250T (lt) 2008-05-21 2019-11-11 Ferring Bv Burnoje disperguojamas desmopresinas, skirtas nikturijos nepertraukiamo miego pirminio periodo pailginimui

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1677095A (en) * 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
KR20040047915A (ko) * 2001-10-15 2004-06-05 룀 게엠베하 운트 콤파니 카게 활성제로서 펩타이드 또는 단백질을 함유하는 생약 형태를제조하기 위한 공중합체의 용도
DE60307082D1 (de) * 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin

Also Published As

Publication number Publication date
TW200528141A (en) 2005-09-01
AR047155A1 (es) 2006-01-11
NO20045657D0 (no) 2004-12-27
ES2254858T3 (es) 2006-06-16
EP1550439B1 (de) 2006-03-08
HK1079696A1 (en) 2006-04-13
PT1550439E (pt) 2006-06-30
ATE319430T1 (de) 2006-03-15
SI1550439T1 (sl) 2006-08-31
NO20045657L (no) 2005-06-30
DK1550439T3 (da) 2006-04-03
EP1550439A1 (de) 2005-07-06
IL165780A0 (en) 2006-01-15
IL189107A0 (en) 2008-06-05
IL202881A0 (en) 2011-07-31
TWI282284B (en) 2007-06-11
DE60303872T2 (de) 2006-10-19

Similar Documents

Publication Publication Date Title
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
ATE447942T1 (de) Verfahren zur herstellung einer gegen missbrauch gesicherten darreichungsform
DE602004031895D1 (de) Verfahren zur Herstellung von Dichlorpropanol
DE60302682D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE60320527D1 (de) Verfahren zur herstellung von grünteepolyphenol
DE60210718D1 (de) Verfahren zur Herstellung einer Reparaturlackierung
DE602004005137D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE602004002651D1 (de) Verfahren zur Herstellung einer Vinylverbindung.
DE10290269T1 (de) Verfahren zur Herstellung von Zyklischem Formal
DE50304687D1 (de) Verfahren zur herstellung von benzophenonen
DE60234275D1 (de) Verfahren zur herstellung von diglyceriden
DE60303872D1 (de) Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE60329036D1 (de) Ökologisches verfahren zur herstellung von brombenzol
DE602004027840D1 (de) Verfahren zur herstellung von thiazolopyrimidinen
DE50211253D1 (de) Verfahren zur Herstellung von Makrokapseln
DE50300002D1 (de) Verfahren zur Herstellung von Polydiorganosiloxanen
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren
DE60327581D1 (de) Verfahren zur Herstellung von Polyalkylsubstituierten aromatischen Aldehyden
DE50311461D1 (de) Verfahren zur herstellung von konjugierter linolsäure
DE602004018447D1 (de) Verfahren zur Herstellung von Alkylbenzaldehyden
DE602004012183D1 (de) Verfahren zur Herstellung von reinem Titanbaustoff
DE60302979D1 (de) Verfahren zur Herstellung von Epsilon-Caprolactone

Legal Events

Date Code Title Description
8363 Opposition against the patent